1

PHA 5782 Pharmacotherapy II Fall 2013 5 Semester Credit Hours

Course Purpose: The purpose of this course is to provide a didactic framework for the pharmacotherapeutic management

of a number of common diseases. The goals of the course are that, coupled with courses in

pathophysiology, pharmacology, pharmacokinetics and others, the student can develop rational drug

therapy plans for patients with common diseases, develop plans for monitoring pharmacotherapy in

patients, and identify conditions associated with these common diseases which require referral.

Course Faculty and Office Hours

Course Coordinator: Jamie Kisgen, Pharm.D., BCPS Email: jkisgen@cop.ufl.edu Phone: 727-394-6213 Teaching Assistant: Marina Suzuki, Pharm.D., Graduate Student Email: kawagucm@ufl.edu Office Hours By appointment only

Place and Time of Class Sessions Gainesville Campus: Monday 4th period 10:40-11:30am HPNP 1404 Section: 4552 9th period 4:05-4:55pm G112 Section: 166F Tuesday 4th period 10:40-11:30am HPNP 1404 Section: 4552 9th period 4:05-4:55pm G301 Section: 166F Wednesday 4th period 10:40-11:30am HPNP 1404 Section: 4552 9th period 4:05-4:55pm G301 Section: 166F Thursday 4th period 10:40-11:30am HPNP 1404 Section: 4552 9th period 4:05-4:55pm C1-7 Section: 166F Friday 4th period 10:40-11:30am G101 Section: 4552 9th period 4:05-4:55pm G103 Section: 166F Note: Review class schedule and monitor ELS announcements for possible exceptions. These times and locations are for Verbal Defense; there is no live class for lectures (unless stated otherwise on course schedule)

Distance Campuses: Refer to campus specific calendar

Co-Coordinator: Karen Whalen, Pharm.D., BCPS, CDE Email: whalen@cop.ufl.edu Phone: 352-273-9497

2

How This Course Relates to the Learning Outcomes You Will Achieve in the

Pharm.D. Program:

This course prepares the Pharm.D. student to accomplish the following student learning outcomes

(SLOs) upon graduation:

1. Develop, integrate, and apply knowledge from the foundational sciences (i.e., pharmaceutical, social/behavioral/administrative, and clinical sciences) to evaluate the scientific literature, explain drug action, solve therapeutic problems, and advance population health and patient-centered care. (Outcome 1.1)

2. Provide patient-centered care as the medication expert (collect and interpret evidence, prioritize patient needs, formulate assessments and recommendations, implement, monitor and adjust plans, and document activities). (Outcome 2.1)

3. Discuss how population-based care influences patient-centered care and influences the development of practice guidelines and evidence-based best practices. (Outcome 2.4)

4. Identify and assess problems; explore and prioritize potential strategies; and design, implement, and evaluate the most viable solution. (Outcome 3.1)

Course Objectives Upon completion of this course, the student will be able to:

1. Integrate knowledge from foundational sciences (e.g., physiological basis of disease, medicinal chemistry, pharmacology, pharmacotherapy, dose optimization) to explain how specific drugs or drug classes work and evaluate their potential value in individuals and populations.

2. Describe appropriate pharmacologic and non-pharmacologic therapies of selected diseases 3. Discuss relationships between rational therapy of selected diseases to the pathophysiology of

these diseases and the mechanism(s) of action of drugs used to treat these diseases 4. Describe the desired outcomes of pharmacotherapy of selected diseases 5. Distinguish between preferred and alternative pharmacotherapy for selected diseases 6. Identify potential drug related problems in patients with selected diseases 7. Assess, based on signs and symptoms of selected diseases, whether a patient should be referred

to a physician and the urgency of the referral 8. Discuss rational, reasonable, and practical solutions to drug related problems in patients with

selected diseases 9. Develop and provide an evidence-based approach that considers the cost, care, access, and

satisfaction needs of a targeted patient population. 10. Formulate evidence based care plans, assessments, and recommendations. 11. Provide a plan for monitoring drug efficacy, adverse effects, compliance and drug interactions 12. Implement the most viable therapeutic solution, including monitoring parameters, to measure

intended and unintended consequences.

Pre-Requisite Knowledge and Skills In order to prepare students to create pharmaceutical care plans for patients with various disease processes, students must have successfully completed the following courses: PHA5560C (PBD I), PHA5561C (PBD II), and PHA5781 (Pharmacotherapy I). Students must be simultaneously taking PHA 5516 (Pharmacology I).

3

Course Structure & Outline

This course provides a thorough overview of pharmacotherapy for a number of common disease states. Students will be responsible for 1) understanding pathophysiology and pharmacology for disease states and 2) completion of assigned readings PRIOR to viewing the lectures. (Note: because of the concurrent nature of pharmacology and this course, certain drugs will be covered in this course prior to being taught in pharmacology – in these situations self-study of the pharmacology of the pertinent drugs will be necessary). Lectures are intended to supplement the assigned reading materials; success in this course is dependent upon mastery of both the lecture and reading content. Students will receive information on current pharmacotherapeutic measures to treat these diseases, as well as principles of monitoring outcomes in patients. This course will emphasize critical thinking and problem solving skills through case presentations, group discussions, and exams.

Most lectures will be pre-recorded prior to the lecture date on the course schedule (refer to Appendix B). Lecture materials and videos will be available approximately one week prior to the scheduled date on the course schedule. Dispersed throughout the semester are 10 Verbal Defense Cases which require students to develop a formal response to questions posed during designated class session. Attendance is required for every case. Cases and questions for discussion during these times will be provided in advance. The PHA 5782 Course website will be maintained through Sakai (http://lss.at.ufl.edu).You will be able to access course announcements, course information, supplemental documents (e.g., case answers, etc), and grades through this website. Students are expected to check the course website regularly (ie, daily) for updated information. Whenever possible, the course coordinators will post an announcement when any new significant information is added to the website.

Textbooks 1. Pharmacotherapy: A Pathophysiologic Approach, 8th Edition, McGraw-Hill. (This text will be available free of charge from www.accesspharmacy.com) 2. Class materials will be posted to the course website for access unless otherwise announced. 3. Required readings which are not contained in Pharmacotherapy: A Pathophysiologic Approach

may be assigned by the lecturer and will be made available on the course website.

Active Learning Requirements During verbal defense, students will be randomly called on to answer questions or make recommendations. Student responses will be assessed by the course facilitator using the criteria listed below.

4

Student Evaluation & Grading Exams: There will be four examinations administered during the course. Three semester exams will be administered on September 26th, October 25th, and November 13th from 7 PM to 9 PM. On the Gainesville campus these exams will be administered in the HPNP Auditorium (1404); for information on the location of exams at other campuses please check with your respective campus calendar and faculty. All exams will be administered using ExamSoft (SofTest), a secure software program that is run on your laptop. All students will be responsible for having a working laptop and battery capable of lasting throughout the exam. Students must also download the encrypted exam before coming to the testing room. All of the exams will be cumulative. New material will compromise approximately 80% of the exam while old material will account for the remaining 20%. The date and time of the Final Exam is December 10th from 12-2pm. Contribution of each exam to a student’s final course grade is summarized in the following table:

Percent of final grade Semester Exam I 20 Semester Exam II 20 Semester Exam III 20 Final Exam 20 Portion of final grade from examinations: 80 Material covered on each exam: Semester Exam I – Lab Values through Glaucoma Semester Exam II – Hyperlipidemia through Heart Failure PLUS Cumulative Material Semester Exam III – Arrhythmias through BCP PLUS Cumulative Material Final Exam – Epilepsy through Insomnia PLUS Cumulative Material Each examination will cover material presented from the lectures, in class as part of Verbal Defense Cases, and from required reading materials. Aside from information about topics covered in this course conveyed during class presentations by faculty and contained in handouts and assigned readings (or optional readings), no source(s) of information outside of these materials will be considered pertinent to this course or its examinations. Questions for each exam will be prepared by lecturers and course coordinators and will come exclusively from the goals and objectives which accompany each lecture topic and the course objectives. The format for these exams will be case-based multiple choice questions. Verbal Defense: Scoring System for Pharmacotherapy II Verbal Defense: A (90, 95, or 100): Students enhance the class. Well prepared for class Answer questions correctly Contribute readily to the discussion but does not dominate it Makes thoughtful contributions that advance the discussion Shows interest in and respect for others' views

5

B (80 or 85): Students contribute to the class. Somewhat prepared for class Shows interest in and respect for others' views May be active participants whose contributions are less cogent than those of other students, but

still advance the conversation

C (70 or 75): Students neither add nor detract to the class. Sometimes prepared Bluffs their way when not prepared Participates in discussion, but not in a way that advances the conversation Exhibits no interest in increasing their participation in class D (60 or 65): Students have a negative effect on the class. Gives minimal responses, or they interrupt the discussion and otherwise impede discussions Is not prepared for class Is late with assignments, absent and tardy without excuse E (≤55): Students disturb the class. Rude Not responsive to expressions of annoyance from the instructor or fellow students Radiates negative energy through hostile or bored body language Has a negative effect on the participation of others Disrupts classroom proceedings

Clinical Documentation:

Prioritized Problem List and Plan

Prior to the Hyperlipidemia and Heart Failure verbal defense case discussions, each student will submit

on Sakai a word document containing a prioritized problem list and therapeutic plan. The prioritized

problem list should list all problems identified for the patient given the available information. The

therapeutic plan must address the primary problem only and should include all drugs, doses, routes,

frequencies, expected duration of therapy (if applicable), and monitoring plan/goals. This prioritized

problem list and plan must be submitted by Noon on the Sunday prior to the scheduled verbal defense

case. (See assignment schedule below and on Sakai)

SOAP Note

Prior to the Hypertension and Diabetes verbal defense classes, each student will submit on Sakai a word

document with a concise SOAP note for the assigned case. The SOAP note should be no more than one

page in length. Font should be in Arial and no smaller than 12 pt with margins no smaller than 0.5".

Your name should be at the bottom of the note to serve as your electronic signature. The SOAP note

must be submitted by Noon on the Sunday prior to the scheduled verbal defense case. (See assignment

schedule below and on Sakai)

6

Grading Scale

The course grade will be determined as follows: Percent of final grade Semester exam 1 20% Semester exam 2 20% Semester exam 3 20% Final exam 20% Verbal Defense 10% Clinical Documentation 10% TOTAL 100% A final percentage grade will be calculated and letter grades assigned as follows: Grade > 93% A 90-92% A- 87-89% B+ 83-86% B 80-82% B- 77-79% C+ 73-76% C 70-72% C- 67-69% D+ 63-66% D 60-62% D- < 60% E Please note that it will not be possible to achieve a passing grade in this course only on the basis of

passing verbal defense and clinical documentation. A passing grade ( 60%) on at least one of the exams is required in order to receiving a passing grade in the course. For more information on the grading policy please refer to the following website. (http://www.registrar.ufl.edu/catalog/policies/regulationgrades.html)

Class Attendance Policy

As a student in the University of Florida College of Pharmacy, you have accepted the responsibility of training to become a health care professional. You will be expected to demonstrate professional attitudes and behavior during class. Specific attitudes and behaviors which are expected are outlined below. Students are required to be on time for class. Arriving late to class causes a disturbance and is considered disrespectful to peers and the instructor. If you are unable to arrive on time, please take a seat near the back with as little commotion as possible. Students will be expected to respect their peers’ right to learn. This expectation includes refraining from the following types of behaviors: loud or distracting conversation during an instructor’s presentation;

7

gathering materials to leave the class before the professor has completed his/her remarks; leaving class during the presentation unless a reasonable circumstance demands such action (e.g., illness); making disrespectful sounds during the class (e.g., hissing); distracting activities during class such as allowing cell phone to ring, reading the newspaper, passing notes, loudly eating food or drinking beverages. Students who are unable to follow these guidelines will be asked to meet with the course coordinators. Every student is expected to treat faculty, staff, and others with respect. In return, each student should expect to be treated with similar respect from faculty, staff, and others. Faculty and staff work to provide a quality educational program for pharmacy students. Misunderstandings, changes in class schedules, and mistakes in administrative aspects of the course will probably occur. All are expected to display mature judgment and abide by the reasonable decisions communicated by faculty and staff. Students who must miss a case discussion due to illness, family emergency, death in the family, or any other unforeseen event should personally report this to either course coordinator (for the Gainesville campus) or the campus facilitator (for the Jacksonville, Orlando, and St Petersburg campuses) PRIOR to presentation of the case. Please note that this information may be transmitted ONLY by the affected student. Any such communication from anyone other than the affected student will be unacceptable. Appropriate and verifiable documentation of the need to miss the case presentation will be required. The following penalty will be applied to the Verbal Defense grade for students with unexcused absences: 1 unexcused absence – Verbal Defense Final Grade lowered by 10%; 2 unexcused absences – Verbal Defense Final Grade lowered by 25% , 3 unexcused absences – Verbal Defense Final Grade lowered by 50%, ≥ 4 unexcused absence – student receives a 0 (zero) for their Verbal Defense Final Grade Verbal defense will represent 10% of your final grade.

Quiz/Exam Policy The exam and exam key with corresponding answer explanation/rationale will be posted within 24 hours of the exam. The validity of each exam question will be determined by the course coordinators. Once the key has been posted, students will have 24 hours to submit rebuttals to exam questions. Rebuttals need to be EVIDENCE-BASED (i.e. NOT “that is what you said in lecture”), NO MORE THAN ONE PAGE IN LENGTH, professional in nature, and emailed to BOTH Dr. Kisgen and Dr. Whalen. The course coordinators will review the rebuttals and contact the lecturer if deemed appropriate. You are NOT to contact the lecturer personally. After the rebuttals have been analyzed, a final announcement will be posted to the course website stating any changes that will occur in the exam grading process. Students arriving late: Students arriving late for an examination may take the exam if and only if no other student has completed the examination and left the examination room at any of the campuses which are testing simultaneously. Once any student has completed the examination and left the examination room on any campus, no late arriving student may take the examination. Once the exam starts, bathroom breaks are not permitted. Please plan accordingly. Students who leave the examination room during the exam will be required to turn in their exam and are prohibited from reentering the room. Calculators There is no need to bring a calculator to the exam since an electronic calculator will be provided by the ExamSoft program (SofTest). Students who wish to use their own non-programmable calculator may do so but sharing of calculators with other students will NOT be permitted.

8

Questions during exams Per College of Pharmacy policy, NO questions will be answered during an examination

Make-up Quiz/Exam Policy Students who must miss a scheduled exam due to illness, family emergency, death in the family, or any other unforeseen event should personally report to the course coordinators. Any such communication from anyone other than the affected student will be unacceptable. Appropriate and verifiable documentation of the need to miss an exam will be required. A make-up exam (essay format) will be scheduled for the student at a reasonable time established by the course coordinator. Only in extreme circumstances will the make-up exam will be administered more than two weeks after the scheduled exam. Unexcused absences from a scheduled examination or failure to notify the course coordinator of an absence will result in the student receiving a zero for that exam.

Policy on Old Quizzes and Assignments N/A

Assignment Deadlines Prioritized Problem List:

Hyperlipidemia: due by Noon on 9/22

Heart Failure: due by Noon on 10/20

SOAP Note:

Hypertension: due by Noon on 9/29

Diabetes: due by Noon on 11/3

General College of Pharmacy Course Policies The College of Pharmacy has a website that lists course policies that are common to all courses. This website covers the following:

1. University Grading Policies 2. Academic Integrity Policy 3. How to request learning accommodations 4. Faculty and course evaluations 5. Student expectations in class 6. Discussion board policy 7. Email communications 8. Religious holidays 9. Counseling & student health 10. How to access services for student success

Please see the following URL for this information:

http://www.cop.ufl.edu/wp-content/uploads/dept/studaff/policies/General%20COP%20Course%20Policies.pdf

9

Complaints

If you have issues with this course, please first contact the course coordinators: Dr. Jamie Kisgen and/or

Dr. Karen Whalen. If you are unhappy with the response, please contact the PTR Department Chair Dr.

Reggie Frye. After following this process, should you have any complaints with your experience in this

course please visit: http://www.distancelearning.ufl.edu/student-complaints

Copyright Pharmacy students are permitted to record and view on their computers, Ipods, Smart phones, and

other video recording equipment the lectures and discussions by faculty; presentations by College of

Pharmacy guests; presentations by graduate and professional students, e.g. via seminars, student

organization meeting, etc.; and, other College of Pharmacy information transmitted by video streaming

per the authorization of faculty and the administration. These video presentations are not for

commercial use or to be shared with others outside of the College of Pharmacy. Use of these video-

captured presentations to anyone other than the intended recipients must be approved in writing by

the faculty member for a course or presenter in other educational formats. Presentations by faculty,

graduate students, pharmacy students, guests, and administrators are intended for use in the UF College

of Pharmacy only. These presentations are the intellectual property of the presenter. Any unauthorized

use of these materials such as providing it to others for profit or use in ways outside the intended use in

the educational programs in the UF College of Pharmacy will be reported to the University of Florida

Office of Student Conduct and Conflict Resolution as a violation of the Student Conduct Code.

Infringement on the intellectual property of presenters is a basis for legal action per copyright and

intellectual property law.

10

Appendix A: Directions for Contacting Faculty & Course Faculty List Course Website The PHA5783 course website will be maintained through Sakai (https://lss.at.ufl.edu). You will be able to access course announcements, course information, supplement documents (ex. Case answers, etc), and grades through this website. Students are expected to check the course website regularly (daily) for updated information. Whenever possible, course coordinators will post announcements when significant information is added to the website. Course Communication All course communication, except for that of a private nature, will occur through guided discussion boards on the course website, in class on Verbal Defense Case days, and via announcement postings. Discussion threads will be organized topically and will be created for general course issues, specific topics, and exam-related issues. If you have a course question, please post it to the appropriate discussion board. The discussion board will be checked and questions answered as promptly as possible (the timeline for a response will not exceed three business days after the original posting). Please keep in mind the following guidelines regarding discussion board postings:

1. Strive to exhibit professionalism through this mechanism of communication 2. Please keep all communication and requests professional. Avoid sarcastic, negative, or insulting

postings, or judging others questions. 3. Please check recent discussion board posts and announcements before posting your message

to ensure that someone else has not already asked the same question, or that it has not been addressed in an announcement.

4. Anonymous postings will not be permitted. 5. Also avoid unnecessary posts such as “thank you”, “me too”, etc

If you have a question of a private nature, please e-mail either course coordinator directly or campus faculty as appropriate. E-mail messages regarding course-related issues will not be answered but referred instead to the website. Course Coordinators: Jamie Kisgen, Pharm.D., BCPS Clinical Assistant Professor Office: St. Petersburg Campus Phone: 727-394-6213 Email: jkisgen@cop.ufl.edu Office hours: By appointment Karen Whalen, Pharm.D., BCPS, CDE Clinical Associate Professor Office: HPNP Phone: 352-273-9497 Email: whalen@cop.ufl.edu Office hours: By appointment

Instructors: Jacksonville: Marci DeLosSantos, Pharm.D., BCPS Cardiology Pharmacy Practitioner UF Health Jacksonville Email: Marci.DeLosSantos@jax.ufl.edu Orlando: Lisa Vandervoort, Pharm.D. Clinical Adjunct Professor Phone: 407-313-7031 Email: lvandervoort@cop.ufl.edu

11

Appendix B. Schedule of Course Activities/Topics – Updated 8/22/2013

Week Date Day Topic Instructor

1

Prior to Start of Class

Introduction to Course Kisgen/Whalen

8/21 Wed Interpreting Laboratory Values Kisgen/Whalen

8/22 Thurs Pediatrics Williams

8/23 Fri Allergic Rhinitis Hendeles

2

8/26 Mon Asthma Hendeles

8/27 Tues Asthma Hendeles

8/28 Wed COPD Hendeles

8/29 Thurs Geriatrics Vogel Anderson

8/29 Thurs AR/Asthma/COPD Case Discussion St. Petersburg: 9:00 to 10:30 Orlando: 1:30 to 3:00

Hendeles

8/30 Fri AR/Asthma/COPD Case Discussion Gainesville Group A and B: 9:30 - 11:30 (G101) Jacksonville: 2:30 - 4:00

3

9/2 Mon Labor Day – No Class

9/3 Tues Urology Vogel Anderson

9/4 Wed Erectile Dysfunction Vogel Anderson

9/5 Thurs Obesity Motycka

9/6 Fri Obesity Motycka

4

9/9 Mon PUD Whalen

9/10 Tues GERD Whalen

9/11 Wed Inflammatory Bowel Disease Snyder

9/12 Thurs Glaucoma Carris

9/13 Fri Hyperlipidemia Cooper-DeHoff

5

9/16 Mon Hyperlipidemia Cooper-DeHoff

9/17 Tues

GI Illnesses

Whalen Group A: 10:40 - 11:30 (HPNP 1404)

Group B: 4:05 - 4:55 (G301)

9/18 Wed Hypertension Cooper-DeHoff

9/19 Thurs Hypertension Cooper-DeHoff

9/20 Fri Hypertension Cooper-DeHoff

6

9/23 Mon Hypertension Cooper-DeHoff

9/24 Tues

Hyperlipidemia Case Presentation

Cooper-DeHoff Group A: 10:40 - 11:30 (HPNP 1404)

Group B: 4:05 - 4:55 (G301)

9/25 Wed Stable Angina Pectoris Cooper-DeHoff

9/26 Thurs Exam One: Lab Values through Glaucoma (7:00 - 9:00pm)

HPNP 1404

9/27 Fri Stable Angina Pectoris Cooper-DeHoff

12

7

9/30 Mon Acute Coronary Syndromes Hamadeh

10/1 Tues

Hypertension Case Discussion

Cooper-DeHoff Group A: 10:40 - 11:30 (HPNP 1404)

Group B: 4:05 - 4:55 (G301)

10/2 Wed Acute Coronary Syndromes Hamadeh

10/3 Thurs Acute Coronary Syndromes Hamadeh

10/4 Fri Heart Failure Anderson

8

10/7 Mon Heart Failure Anderson

10/8 Tues

Stable Angina Pectoris

Cooper-DeHoff Group A: 10:40 - 11:30 (HPNP 1404)

Group B: 4:05 - 4:55 (G301)

10/9 Wed Heart Failure Anderson

10/10 Thurs Heart Failure Anderson

10/11 Fri Arrhythmias Ashton

9

10/14 Mon Arrhythmias Ashton

10/16 Tues Arrhythmias Ashton

10/17 Wed Thromboembolic Disorders Vogel Anderson

10/17 Thurs

Acute Coronary Syndromes

Hamadeh Group A: 10:40 - 11:30 (HPNP 1404)

Group B: 4:05 - 4:55 (C1-7)

10/18 Fri Thromboembolic Disorders Vogel Anderson

10

10/21 Mon Diabetes Taylor

10/22 Tues

Heart Failure Case Discussion

Anderson Group A: 10:40 - 11:30 (HPNP 1404)

Group B: 4:05 - 4:55 (G301)

10/23 Wed Diabetes Taylor

10/24 Thurs Diabetes Taylor

10/25 Fri Exam Two: Hyperlipidemia through Heart Failure PLUS Cumulative Material (7:00-9:00pm)

HPNP 1404

11

10/28 Mon Diabetes Taylor

10/29 Tues Thyroid Weitzel

10/30 Wed

VTE Case Discussion

Vogel Anderson Group A: 10:40 - 11:30 (HPNP 1404)

Group B: 4:05 - 4:55 (G301)

10/31 Thurs Menopause St. Onge

11/1 Fri Osteoporosis Whalen

12

11/4 Mon No Class

11/5 Tues

Diabetes Case Discussion

Taylor Group A: 10:40 - 11:30 (HPNP 1404)

Group B: 4:05 - 4:55 (G301)

11/6 Wed BCP (LIVE LECTURE - HPNP 1404: 10:40 -11:30) Gums

BCP (LIVE LECTURE - HPNP G101: 11:45 -12:35) Gums

11/7 Thurs Epilepsy Voils

11/8 Fri Homecoming – No Class

13

13

11/11 Mon Veteran’s Day – No Class

11/12 Tues Epilepsy Voils

11/13 Wed Exam Three: Arrhythmias through BCP PLUS Cumulative Material (7:00 - 9:00pm)

HPNP 1404

11/14 Thurs Bipolar Disorder Markowitz

11/15 Fri Bipolar Disorder Markowitz

14

11/18 Mon Parkinson's Disease Markowitz

11/19 Tues

Bipolar Case Discussion

Markowitz Group A: 10:40 - 11:30 (HPNP 1404)

Group B: 4:05 - 4:55 (G301)

11/20 Wed Schizophrenia Markowitz

11/21 Thurs Schizophrenia Markowitz

11/22 Fri Depression Markowitz

15

11/25 Mon Depression Markowitz

11/26 Tues Alzheimer’s Disease Markowitz

11/27 Wed

Thanksgiving Break – No Class 11/28 Thurs

11/29 Fri

16

12/2 Mon Attention Deficit Hyperactivity Disorder Markowitz

12/3 Tues Anxiety Cogan

12/4 Wed Insomnia St. Onge

12/10 Tues Final Exam: Epilepsy through Insomnia PLUS Cumulative Material

HPNP 1404

Note: All verbal defense dates, times, and locations listed above are for the Gainesville campus. For Jacksonville, Orlando, and St. Petersburg campuses, please check your local schedule for times and locations.